US Lawmakers Praise FDA Tips On Coordinated Vulnerability Programs For Device Cybersecurity
Executive Summary
A US House Energy and Commerce Committee white paper supporting coordinated vulnerability disclosure (CVD) as a method of facilitating third-party investigations of cybersecurity breaches praised US FDA’s recommendations to medtech manufacturers.
You may also be interested in...
Siemens Cybersecurity Expert Says Medtech Industry Has 'Perverse Incentive' To Not Disclose Vulnerabilities – Might A New Law Be The Fix?
The fear of losing business by being transparent about cybersecurity vulnerabilities means there's "a perverse incentive in some parts of the market that encourages a lack of disclosure," Siemens' Harrison Wadsworth says. But the US FDA's Suzanne Schwartz believes coordinated vulnerability disclosure legislation could "level the playing field."
'Sharing' Organizations Stay In Final Post-Market Cybersecurity Guidance
Despite pushback from industry groups on the use of information-sharing and analysis organizations (ISAOs), US FDA has kept the language the same in its final post-market cybersecurity guidance, but has removed the term "essential clinical performance."
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.